PLK4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.255400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.295000E-01
Normal-vs-Stage2
7.639400E-01
Normal-vs-Stage3
5.465200E-01
Normal-vs-Stage4
8.926000E-01
Stage1-vs-Stage2
3.927600E-01
Stage1-vs-Stage3
8.115000E-01
Stage1-vs-Stage4
7.121200E-01
Stage2-vs-Stage3
2.986800E-01
Stage2-vs-Stage4
9.193800E-01
Stage3-vs-Stage4
5.082400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.844600E-01
Normal-vs-AfricanAmerican
8.382200E-01
Normal-vs-Asian
8.174200E-01
Caucasian-vs-AfricanAmerican
4.845600E-01
Caucasian-vs-Asian
3.830800E-01
AfricanAmerican-vs-Asian
9.528200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.559200E-01
Normal-vs-Female
6.952600E-01
Male-vs-Female
1.410390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.838400E-01
Normal-vs-Age(41-60Yrs)
6.117200E-01
Normal-vs-Age(61-80Yrs)
9.653800E-01
Normal-vs-Age(81-100Yrs)
6.856800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.451180E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.140600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.935010E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.410500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.901000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.460400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.505400E-01
Normal-vs-Daily Drinker
8.474000E-01
Normal-vs-Weekly Drinker
9.669600E-01
Normal-vs-Occasional Drinker
6.122200E-01
Normal-vs-Social Drinker
7.456400E-01
Non Drinker-vs-Daily Drinker
8.184600E-01
Non Drinker-vs-Weekly Drinker
9.730600E-01
Non Drinker-vs-Occasional Drinker
4.127600E-01
Non Drinker-vs-Social Drinker
6.588200E-01
Daily Drinker-vs-Weekly Drinker
8.166200E-01
Daily Drinker-vs-Occasional Drinker
5.135400E-01
Daily Drinker-vs-Social Drinker
7.912000E-01
Weekly Drinker-vs-Occasional Drinker
4.601200E-01
Weekly Drinker-vs-Social Drinker
6.741000E-01
Occasional Drinker-vs-Social Drinker
7.309400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.697000E-01
Normal-vs-Grade 2
7.996000E-01
Normal-vs-Grade 3
8.737000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.178600E-04
Grade 1-vs-Grade 3
9.63349999999474E-05
Grade 1-vs-Grade 4
6.697000E-01
Grade 2-vs-Grade 3
1.248010E-01
Grade 2-vs-Grade 4
7.996000E-01
Grade 3-vs-Grade 4
8.737000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.778800E-01
Normal-vs-NonDiabetic
7.762800E-01
Diabetic-vs-NonDiabetic
3.235800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.049200E-01
Normal-vs-NoPancreatitis
8.566600E-01
Pancreatitis-vs-NoPancreatitis
7.742800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.527000E-01
Normal-vs-N1
7.705800E-01
N0-vs-N1
6.816600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.269000E-01
Normal-vs-TP53-NonMutant
9.855600E-01
TP53-Mutant-vs-TP53-NonMutant
1.60974999999786E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
